Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening,
- PDF / 945,048 Bytes
- 12 Pages / 595.276 x 790.866 pts Page_size
- 7 Downloads / 202 Views
(2020) 20:919
RESEARCH ARTICLE
Open Access
Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 – 2018 Jessica Michelle Guggenbühl Noller1,2†, Guenter Froeschl1,2*† , Philip Eisermann3, Johannes Jochum4, Stefanie Theuring5, Ingrid Reiter-Owona6, Alfred Lennart Bissinger7, Michael Hoelscher1,8, Abhishek Bakuli1, Franz-Josef Falkner von Sonnenburg1ˆ, Camilla Rothe1, Gisela Bretzel1, Pedro Albajar-Viñas9, Lise Grout9 and Michael Pritsch1
Abstract Background: The highly complex and largely neglected Chagas disease (CD) has become a global health problem due to population movements between Latin America and non-endemic countries, as well as non-vectorial transmission routes. Data on CD testing and treatment from routine patient care in Germany of almost two decades was collected and analysed. Methods: German laboratories offering diagnostics for chronic Trypanosoma cruzi (T. cruzi) infection in routine patient care were identified. All retrievable data on tests performed during the years of 2000–2018 were analysed. Additional clinical information regarding patients diagnosed with CD was collected through questionnaires. (Continued on next page)
* Correspondence: [email protected] † Jessica Michelle Guggenbühl Noller and Guenter Froeschl contributed equally to this work. ˆFranz-Josef Falkner von Sonnenburg is deceased. 1 Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany 2 Center for International Health, University Hospital, LMU Munich, Munich, Germany Full list of author information is available at the end of the article © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Guggenbühl Noller et al. BMC Infectious Diseases
(2020) 20:919
Page 2 of 12
(Continued from previous page)
Results: Five German laboratories with diagnostics for T. cruzi infection in routine patient care were identified. Cen
Data Loading...
